Literature DB >> 15048879

Sp1-dependent regulation of the tissue inhibitor of metalloproteinases-1 promoter.

Minhyung Lee1, Sun U Song, Ji Kan Ryu, Jun Kyu Suh.   

Abstract

Extracellular matrix (ECM) remodeling is involved in many cellular properties such as division, migration, differentiation, and death. The turnover of ECM is regulated by matrix metalloproteinases (MMPs) and the MMPs are inhibited by the tissue inhibitors of metalloproteinases (TIMPs). In this study, the transcriptional regulation of the TIMP-1 promoter was investigated. The 5'-deletion assay showed that the region between -1,200 and -1,101 was responsible for the TIMP-1 promoter activity. The mutations of the two Sp1 sites in this region reduced the transcription activity. In addition, the co-transfection with antisense Sp1 oligonucleotide decreased the promoter activity, suggesting that the transcription of the TIMP-1 promoter is mediated by Sp1. Previously, it was reported that the TIMP-1 expression was enhanced under hypoxia. Therefore, the TIMP-1 promoter activity was investigated with or without cobalt ion, which elicits the same physiological effect as hypoxia. The results showed that the TIMP-1 promoter was induced in the presence of cobalt ion and that the promoter activity was regulated by Sp1 as well as HIF-1. Therefore, this study suggests that Sp1 is involved in the regulation of the TIMP-1 promoter in the presence of cobalt ion as well as in the basal level transcription. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048879     DOI: 10.1002/jcb.20021

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism.

Authors:  Songbai Lin; Neeraj K Saxena; Xiaokun Ding; Lance L Stein; Frank A Anania
Journal:  Mol Endocrinol       Date:  2006-08-24

2.  Analysis of key genes and related transcription factors in liver fibrosis based on bioinformatic technology.

Authors:  Xue Yang; Qi-Ni Cheng; Jiang-Feng Wu; Wen-Bing Ai; Lan Ma
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

3.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 4.  Hypoxia-responsive transcription factors.

Authors:  Eoin P Cummins; Cormac T Taylor
Journal:  Pflugers Arch       Date:  2005-07-09       Impact factor: 3.657

5.  Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo.

Authors:  Guang-Feng Shi; Qian Li
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

6.  Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis.

Authors:  Gibran Ali; Sadia Mohsin; Mohsin Khan; Ghazanfar Ali Nasir; Sulaiman Shams; Shaheen N Khan; Sheikh Riazuddin
Journal:  J Transl Med       Date:  2012-04-25       Impact factor: 5.531

7.  Adiponectin upregulates prolyl-4-hydroxylase α1 expression in interleukin 6-stimulated human aortic smooth muscle cells by regulating ERK 1/2 and Sp1.

Authors:  Li Li; Ke Zhang; Xiao-Jun Cai; Min Feng; Yun Zhang; Mei Zhang
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

8.  Inhibition of the invasion and metastasis of mammary carcinoma cells by NBD peptide targeting S100A4 via the suppression of the Sp1/MMP‑14 axis.

Authors:  Keizo Takenaga; Takahiro Ochiya; Hideya Endo
Journal:  Int J Oncol       Date:  2021-01-21       Impact factor: 5.650

9.  In vitro reversion of activated primary human hepatic stellate cells.

Authors:  Adil El Taghdouini; Mustapha Najimi; Pau Sancho-Bru; Etienne Sokal; Leo A van Grunsven
Journal:  Fibrogenesis Tissue Repair       Date:  2015-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.